ArticleJournal of cancer research and clinical oncology2021

Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials.

Stefanie Noepel-Duennebacke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.